Home Arena - Flatness In Scripts Will Impact The Equity
 

Keywords :   


Arena - Flatness In Scripts Will Impact The Equity

2015-05-09 04:01:10| Biotech - Topix.net

Arena Pharmaceuticals has seen sales of the anti-obesity drug Belviq flatten out over the past few weeks while competitor Contrave from Orexigen continues to close the gap. Over the last two months Belviq sales have gained less than 1% and have moved from about 14,100 scripts in the first week in March to about 14,800 scripts at the close of April.

Tags: the impact equity scripts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »